Hostname: page-component-5f745c7db-q8b2h Total loading time: 0 Render date: 2025-01-06T06:51:52.232Z Has data issue: true hasContentIssue false
  • English
  • Français

Hypertrophic cardiomyopathy as the initial presentation of mitochondrial disease in an infant born to a diabetic mother

Published online by Cambridge University Press:  23 March 2023

Jun Chul Byun  and
Hee Joung Choi Open the ORCID record for Hee Joung Choi [Opens in a new window]
Jun Chul Byun
Affiliation:
Department of Pediatrics, Keimyung University School of Medicine, Keimyung University Dongsan Medical Center, Daegu, Republic of Korea
Hee Joung Choi*
Affiliation:
Department of Pediatrics, Keimyung University School of Medicine, Keimyung University Dongsan Medical Center, Daegu, Republic of Korea
*
Author for correspondence: Hee Joung Choi, MD, Department of Pediatrics, Keimyung University School of Medicine, 1095 Dalgubeol-daero, Dalseo-gu, Daegu 42601, Republic of Korea. Tel: +82 53 258 7312; Fax: +82 53 258 7319. E-mail: joung756@dsmc.or.kr
Get access Rights & Permissions [Opens in a new window]

Abstract

In contrast to hypertrophic cardiomyopathy caused by maternal diabetes, neonatal mitochondrial cardiomyopathy is rare and has a poor prognosis. We report an infant born to a mother with maternal diabetes with persistent ventricular hypertrophy, who was diagnosed with mitochondrial disease associated with m.3243A>G mutation in a mitochondrial tRNA leucine 1 gene. The hypertrophic cardiomyopathy was his initial and only clinical presentation.

Keywords

Hypertrophic cardiomyopathymitochondrial cardiomyopathyMT-TL1 mutationinfant of a diabetic mother
Type
Brief Report
Information
Cardiology in the Young , Volume 33 , Issue 9 , September 2023 , pp. 1743 - 1745
Check for updates
Copyright
© The Author(s), 2023. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Hornberger, LK. Maternal diabetes and the fetal heart. Heart 2006; 92: 1019–1021.10.1136/hrt.2005.083840CrossRefGoogle ScholarPubMed
Seok, H, Oh, JH. Hypertrophic cardiomyopathy in infants from the perspective of cardiomyocyte maturation. Korean Circ J 2021; 51: 733–751.10.4070/kcj.2021.0153CrossRefGoogle ScholarPubMed
Niedermayr, K, Pölzl, G, Scholl-Bürgi, S, et al. Mitochondrial DNA mutation "m.3243A>G"-heterogeneous clinical picture for cardiologists ("m.3243A>G": A phenotypic chameleon). Congenit Heart Dis 2018; 13: 671–677.10.1111/chd.12634CrossRefGoogle ScholarPubMed
Brambilla, A, Favilli, S, Olivotto, I, et al. Clinical profile and outcome of cardiac involvement in MELAS syndrome. Int J Cardiol 2019; 276: 14–19.10.1016/j.ijcard.2018.10.051CrossRefGoogle ScholarPubMed
Oh, JH, Hong, YM, Choi, JY, et al. Idiopathic cardiomyopathies in Korean children. 9-year Korean multicenter study. Circ J 2011; 75: 2228–2234.10.1253/circj.CJ-11-0051CrossRefGoogle ScholarPubMed
Holmgren, D, Wåhlander, H, Eriksson, BO, Oldfors, A, Holme, E, Tulinius, M. Cardiomyopathy in children with mitochondrial disease; clinical course and cardiological findings. Eur Heart J 2003; 24: 280–288.10.1016/S0195-668X(02)00387-1CrossRefGoogle ScholarPubMed
Imai-Okazaki, A, Kishita, Y, Kohda, M, et al. Cardiomyopathy in children with mitochondrial disease: prognosis and genetic background. Int J Cardiol 2019; 279: 115–121.10.1016/j.ijcard.2019.01.017CrossRefGoogle ScholarPubMed
Wortmann, SB, Rodenburg, RJ, Backx, AP, Schmitt, E, Smeitink, JA, Morava, E. Early cardiac involvement in children carrying the A3243G mtDNA mutation. Acta Paediatr 2007; 96: 450–451.10.1111/j.1651-2227.2006.00158.xCrossRefGoogle ScholarPubMed